University of Queensland
UQ researchers have been awarded almost $1 million through the Australia-India Strategic Research Fund (AISRF) to combat the threat of antimicrobial resistance to human health.
Led by Professor Mark Blaskovich from the Institute for Molecular Bioscience, the project will combine research from UQ and AbGenics Life Sciences in India to support the development of new drugs and diagnostics to address this global challenge.
UQ researchers will characterise antibodies developed by AbGenics and create derivatives with enhanced abilities to detect and kill bacteria.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
